Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2024 at "RMD Open"
DOI: 10.1136/rmdopen-2024-004190
Abstract: Objective Previous technical limitations prevented the proof of Fcγ-receptor (FcγR)-activation by soluble immune complexes (sICs) in patients. FcγRIIIa (CD16) is a risk factor in rheumatoid arthritis (RA). We aimed at determining the presence of CD16-activating… read more here.
Keywords: bioactivity; immune complexes; rheumatoid arthritis; circulating sics ... See more keywords